A Phase I Study of MEDI9447 (Oleclumab) in Japanese Participants

Trial Identifier:	D6070C00006
Sponsor:	AstraZeneca
NCTID::	NCT03736473
Start Date:	November 2018
Primary Completion Date:	June 2019
Study Completion Date:	June 2019
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Chuo-ku, JP, 104-0045

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.